Method of operating redundant staggered disease management systems
US12128213B2 · kind B2 · utility
38Cited by
494References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2021 |
| Grant date | Oct 29, 2024 |
| Priority date | — |
| Expiry date | Dec 1, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2230/201
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A system which provides closed loop insulin administration is disclosed. The system includes redundant glucose sensors which may be interleaved in order to provide monitoring when one of the glucose sensors is in a settling period. The system may include a disease management unit which includes both a glucose sensor and an insulin pump. A closed loop disease management system which bases insulin administration on accurate glucose measurements may improve a patient's quality of life.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.